Sleep Apnea and the Disability Tax Credit Canada 2026

Sleep apnea is often difficult to support for the DTC unless CRA’s life-sustaining therapy or marked restriction criteria are met. This guide explains when the rules may apply.

Quick Answer

Sleep apnea rarely qualifies for the Disability Tax Credit Canada in 2026. Although CPAP is technically life-sustaining therapy, the CRA's 14-hour weekly threshold counts active therapy management time, not hours wearing the device while asleep. Most CPAP setup, maintenance, and management totals well under 14 hours per week, so straightforward sleep apnea claims usually fail.

Educational purposes only. Sleep apnea DTC eligibility is unusual and difficult. Consult a qualified tax professional for individual advice.

The CRA Position on Sleep Apnea

The DTC has a specific pathway called life-sustaining therapy for conditions that require ongoing medical therapy to support a vital function. Examples that clearly qualify include insulin-dependent Type 1 diabetes (when therapy time totals 14+ hours per week) and chronic dialysis. CPAP therapy for sleep apnea is, on paper, life-sustaining, but the CRA applies a narrow interpretation that excludes most CPAP users.

The key distinction: the 14-hour rule counts active management time, not passive time while the device is operating. Time spent asleep with CPAP running does not count toward the 14 hours.

What Counts Toward the 14-Hour Threshold

  • Setting up and adjusting the device daily
  • Cleaning equipment (mask, tubing, water chamber)
  • Replacing supplies (filters, masks, headgear)
  • Monitoring data and adjusting settings
  • Travelling to sleep medicine appointments and titration studies
  • Active troubleshooting (mask leaks, pressure issues)

Realistically, most CPAP users spend 1-3 hours per week on active management, well below the 14-hour threshold. The CRA has consistently denied straightforward CPAP-only claims for this reason.

When Could a Sleep Apnea DTC Claim Succeed

A small subset of sleep-disordered breathing cases may qualify:

  • Complex sleep-disordered breathing requiring bilevel ventilation (BiPAP/ASV), with multiple daily settings adjustments and active management
  • Tracheostomy-dependent breathing support requiring daily cleaning, suctioning, and tube management
  • Combined respiratory therapies, when sleep apnea coexists with COPD, neuromuscular disease, or chest wall disease, and the combined therapy time legitimately reaches 14+ hours per week
  • Severe untreated sleep apnea with cognitive impact, in patients who cannot tolerate CPAP and experience severe daytime cognitive impairment, a mental functions category claim may be possible (rare)

If your situation matches one of these, careful documentation by a sleep specialist or respirologist is essential.

What If My Sleep Apnea Causes Daytime Cognitive Impairment

Severe, untreated sleep apnea can cause significant daytime sleepiness, memory problems, and cognitive impairment. In theory, this could support a mental functions claim. However, the CRA expects appropriate treatment to be in place. If CPAP could be tolerated but the patient chooses not to use it, the claim will likely fail. If CPAP intolerance is genuine and well-documented (multiple mask trials, surgical interventions, oral appliance trials, all failed), the claim becomes more credible.

2026 DTC Amounts (If Approved)

If approved on any pathway, the federal credit is $1,448 per year. Combined federal plus provincial credit ranges from $2,047 (Ontario) to $3,708 (Québec). Retroactive claims for up to 10 years are possible if eligibility can be demonstrated for prior years.

Estimate Your DTC Amount

Real severe sleep apnea Filing Scenario

The following example is illustrative. It describes a typical filing flow and does not predict any individual outcome.

A resident with severe central sleep apnea requiring nightly bilevel positive airway pressure (BiPAP) therapy was assessed by her respirologist for the life-sustaining therapy route. Part B documented BiPAP use averaging 8 hours per night, plus weekly equipment maintenance and pulmonary follow-up appointments. The respirologist's weekly therapy log showed the combined time meeting the 14-hour-per-week threshold for life-sustaining therapy. The Notice of Determination arrived 11 weeks after submission, approving the DTC retroactive to the year of diagnosis. Note: standard obstructive sleep apnea cases commonly fail this route because CPAP time alone rarely meets the threshold.

Documentation That Works for severe sleep apnea Part B

What worked in this Part B: a clear weekly log meeting the 14-hour threshold, plus the respirologist's certification that the therapy is life-sustaining for this specific case. Sleep apnea claims succeed for severe central or complex cases requiring intensive therapy; routine CPAP-only obstructive apnea rarely meets the criteria. See our cumulative effects rule guide for the technical framework CRA reviewers apply, and our DTC denied appeal guide if a previous application was rejected.

Frequently Asked Questions

Type 1 diabetes management (blood glucose testing 4-10 times daily, carbohydrate counting, insulin calculation, pump or pen administration, dose adjustment for activity and meals) genuinely consumes 14+ hours per week of active therapy time. CPAP, despite being life-sustaining, requires much less active management once a patient is established on therapy.

Severity of the underlying condition is not the test. The CRA's question is whether your daily therapy management reaches 14+ hours per week, or whether you have marked functional restriction in another category despite appropriate treatment. AHI severity alone does not determine eligibility.

Central or complex sleep apnea requiring adaptive servo-ventilation (ASV) or bilevel therapy has slightly stronger claims because management is more complex. The total therapy time still needs to meet the 14-hour threshold to qualify under life-sustaining therapy.

If you genuinely meet one of the narrow pathways described above (tracheostomy, combined therapies, severe CPAP intolerance with cognitive impact), it can be worth applying with strong specialist documentation. For typical CPAP-only sleep apnea, the claim is very likely to be denied. Consult a tax professional or DTC specialist before investing time in the application.

Official Sources and Related Guides

This condition guide is based on CRA's Disability Tax Credit criteria and official Form T2201 instructions. Use it with our DTC eligibility guide, T2201 form guide, and DTC calculator. For questions about your own facts, contact Disability Tax Credits Canada or speak with a qualified Canadian tax professional.

How CRA Reviews Sleep Apnea Evidence

For sleep apnea claims, the CRA does not approve or deny the Disability Tax Credit based on the diagnosis name alone. The reviewer looks for a severe and prolonged impairment that creates a marked restriction in one basic activity of daily living, a cumulative effect across more than one activity, or qualifying life-sustaining therapy. The strongest files connect the medical history to everyday function using dates, treatment history, frequency, and examples from ordinary routines.

Good sleep apnea documentation should explain what still happens after treatment, accommodations, medication, assistive devices, or family support are already in place. This helps avoid a common weakness in DTC applications: describing symptoms without showing how those symptoms restrict daily activities at least 90 percent of the time.

  • Functional examples: describe what the person cannot do, needs extra time to do, or can only do with support.
  • Frequency and duration: connect the restriction to CRA's 90 percent and 12-month standards where applicable.
  • Clinical evidence: include treatment history, specialist notes, test results, medication trials, therapy records, or assistive-device use when relevant.
  • Tax context: use the DTC calculator only as an estimate after understanding eligibility through the main DTC guide.

Building a Safer Sleep Apnea Application Path

Before submitting Form T2201, compare the medical practitioner's Part B wording against CRA's published categories. If the evidence is borderline, our cumulative effects guide can help identify whether multiple moderate restrictions combine into a marked overall limitation. If a previous claim was denied, review the exact denial reason before sending new information; a stronger appeal usually responds to the CRA's stated concern rather than repeating the first application.

Think You May Qualify Estimate Your DTC Amount.